# iBio (IBIO) — Overview

IBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ibio

## Price

Last close $0.78 on Oct 15, 2026. 52-week range $0.78 – $3.07.

## Company profile

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $100,000.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $100,000.00 |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$33.0M |
| Net income (quarter) | −$10.6M |
| Net income growth (year over year) | -105.33% |
| Net margin | -33044.00% |
| Return on equity | -65.70% |
| EPS (trailing twelve months) | −$0.32 |
| Book value per share | $1.54 |
| P/E (trailing twelve months) | — |
| Price to book | 0.6 |
| Debt to assets | 13.52% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is iBio (IBIO) profitable?

No. iBio reported a net loss of $33.0M over the trailing twelve months.

### How much revenue does iBio (IBIO) make?

iBio generated $100,000.00 in revenue over the trailing twelve months.

### How do I buy stock in iBio (IBIO)?

IBIO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).